IRLAB Therapeutics AB

IRLAB Therapeutics AB

Broadcast on: January 25, 2022
Duration: 11:36

IRLAB is dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). IRLAB strive to transform the everyday life for patients who lack effective treatment options.

  • CEO

    Dr. Nicholas Waters, CEO, IRLAB

    Dr. Nicholas Waters worked as a Ph.D. student in Nobel Laureate Professor Arvid Carlsson’s research group at the Department of Pharmacology, Göteborg University (1987-1995). In 1996, Nicholas was awarded the Swedish Brain Foundation award. Between 1995 and 2000, he was managing research collaborations between the University and Pharma Industry partners. In 1998, he co-founded Carlsson Research. In the years 1998-2002, he served as member of the board of directors at Carlsson Research. In 2002, he was appointed Chief Scientific Officer at Carlsson Research and in 2006 he was appointed CEO. In 2006, Carlsson Research was sold to NeuroSearch and changed name to NeuroSearch Sweden. In 2010 he was appointed Executive Vice President, Research at NeuroSearch. Nicholas continued to serve as CEO of NeuroSearch Sweden through 2012. In 2013, Nicholas co-founded IRLAB. During the years 2007-2010 he served as board member of SwedenBIO, the Swedish Biotech industry association. Nicholas holds a Ph.D. in Pharmacology.

More from OETV

What's happening on OETV

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

X

We value your privacy

This website or its third party tools uses cookies, which are necessary for its functioning and required to achieve the purpose illustrated in our Privacy Policy. By clicking "Accept" or dismissing this notice, you agree to our website's use of cookies.